Chemcrux Enterprises Limited

Equities

540395

INE298W01016

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:52 2024-06-20 am EDT 5-day change 1st Jan Change
233.7 INR +1.39% Intraday chart for Chemcrux Enterprises Limited -0.87% -23.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2023-24 CI
Chemcrux Enterprises Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Chemcrux Enterprises Names CFO MT
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Chemcrux Enterprises Limited Announces Resignation of Mr. Krutarth Parikh as Chief Financial Officer, Effective 13 September 2023 CI
Chemcrux Enterprises Limited Announces Board Changes CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2022-23 CI
Chemcrux Enterprises Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Chemcrux Enterprises Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as Independent Director CI
Chemcrux Enterprises Limited Approves Final Dividend for the Financial Year Ended 31 March 2022 CI
Chemcrux Enterprises Limited Proposes Final Dividend for the Financial Year Ended 31 March 2022 CI
Chemcrux Enterprises Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Chemcrux Enterprises Limited Recommends Final Dividend for Fiscal Year 2021-22 CI
Chemcrux Enterprises Gets Local Bourse BSE's Approval in Principle to Move to Main Board MT
Chemcrux Enterprises Gets Environment Clearance to Expand Manufacturing of Synthetic Organic Chemicals MT
Chemcrux Enterprises and Kalintis Healthcare to Set Up New Joint Venture MT
Chemcrux Enterprises Limited Announces Resignation of Sidhdhi Girishkumar Shah as Non-Executive Non-Independent Director CI
Chemcrux Enterprises Limited Appoints Mukund Prahlad Bakshi as an Additional Director CI
Chemcrux Enterprises Limited completed the acquisition of a 50% stake in Kalichem Private Limited. CI
Chemcrux Enterprises Limited Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Chemcrux Enterprises : to Acquire 50% Stake in Indian Chemicals Manufacturer MT
Chemcrux Enterprises Limited (BSE : 540395) agreed to acquire a 50% stake in Kalichem Private Limited. CI
Chart Chemcrux Enterprises Limited
More charts
Chemcrux Enterprises Limited is an India-based company. The Company is engaged in manufacturing intermediates for bulk drugs, dyes and pigment industries. It is engaged in manufacturing or processing of bulk drug intermediates like Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. The Company's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid. It is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Company’s manufacturing facility is located in Bharuch, Gujarat, India.
More about the company
  1. Stock Market
  2. Equities
  3. 540395 Stock
  4. News Chemcrux Enterprises Limited
  5. Chemcrux Enterprises : to Acquire 50% Stake in Indian Chemicals Manufacturer